Buteyko method reduces Hyperventilation

(BioMindmap Proof Quality is Low.)

1.3 ValidityScore

Valid or Invalid? Login to vote or flag.

Be aware! From other researches we also know that

1999

Buteyko breathing techniques in asthma: a blinded randomised controlled trial.
Bowler SD, et al.
«RESULTS: No change in daily PEF or FEV1 was noted in either group. At three months, the BBT group had a median reduction in daily beta 2-agonist dose of 904 micrograms (range, 29 micrograms to 3129 micrograms), whereas the control group had a median reduction of 57 micrograms (range, -2343 micrograms to 1143 micrograms) (P = 0.002). Daily inhaled steroid dose fell 49% (range, -100% to 150%) for the BBT group and 0 (range, -82% to +100%) for the control group (P = 0.06). A trend towards greater improvement in QOL score was noted for BBT subjects (P = 0.09). Initial MV was high and similar in both groups; by three months, MV was lower in the BBT group than in the control group (P = 0.004). ET CO2 was low in both groups and did not change with treatment.

CONCLUSION: Those practising BBT reduced hyperventilation and their use of beta 2-agonists. A trend toward reduced inhaled steroid use and better quality of life was observed in these patients without objective changes in measures of airway calibre.»
#Adolescent, Adrenergic beta-Agonists, Adult, Aged, Albuterol, Asthma, Bronchodilator Agents, Child, Combined Modality Therapy, Double-Blind Method, Female, Humans, Male, Middle Aged, Quality of Life, Respiratory Function Tests, Salmeterol Xinafoate, Steroidsmore...
ncbi.nlm.nih.gov/pubmed/9887897
PMID:9887897

ranked